| Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. L Malcovati, U Germing, A Kuendgen, MG Della Porta, C Pascutto, ... Journal of clinical oncology 25 (23), 3503-3510, 2007 | 1294 | 2007 |
| The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia A Kuendgen, M Schmid, R Schlenk, S Knipp, B Hildebrandt, C Steidl, ... Cancer 106 (1), 112-119, 2006 | 294 | 2006 |
| Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or … A Kuendgen, S Knipp, F Fox, C Strupp, B Hildebrandt, C Steidl, ... Annals of hematology 84, 61-66, 2005 | 202 | 2005 |
| Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes U Germing, C Strupp, A Kuendgen, S Isa, S Knipp, B Hildebrandt, ... Haematologica 91 (12), 1596-1604, 2006 | 197 | 2006 |
| Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q M Mallo, J Cervera, J Schanz, E Such, G García-Manero, E Luno, C Steidl, ... Leukemia 25 (1), 110-120, 2011 | 160 | 2011 |
| Intensive chemotherapy is not recommended for patients aged> 60 years who have myelodysplastic syndromes or acute myeloid leukemia with high‐risk karyotypes S Knipp, B Hildebrand, A Kündgen, A Giagounidis, G Kobbe, R Haas, ... Cancer 110 (2), 345-352, 2007 | 158 | 2007 |
| Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del (5q): a multicenter study U Germing, M Lauseker, B Hildebrandt, A Symeonidis, J Cermak, ... Leukemia 26 (6), 1286-1292, 2012 | 149 | 2012 |
| Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes A Matsuda, U Germing, I Jinnai, M Misumi, A Kuendgen, S Knipp, ... Blood 106 (8), 2633-2640, 2005 | 143 | 2005 |
| Chronic myelomonocytic leukemia in the light of the WHO proposals U Germing, C Strupp, S Knipp, A Kuendgen, A Giagounidis, B Hildebrandt, ... Haematologica 92 (7), 974-977, 2007 | 99 | 2007 |
| Validation of the revised international prognostic scoring system (IPSS-R) in patients with myelodysplastic syndrome: a multicenter study J Neukirchen, M Lauseker, S Blum, A Giagounidis, M Lübbert, S Martino, ... Leukemia research 38 (1), 57-64, 2014 | 90 | 2014 |
| Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes J Neukirchen, S Blum, A Kuendgen, C Strupp, M Aivado, R Haas, C Aul, ... European journal of haematology 83 (5), 477-482, 2009 | 82 | 2009 |
| Acute leukemia in the time of COVID-19 M Gavillet, JC Klappert, O Spertini, S Blum Leukemia research 92, 106353, 2020 | 78 | 2020 |
| Evaluation of the prognostic significance of eosinophilia and basophilia in a larger cohort of patients with myelodysplastic syndromes F Wimazal, U Germing, M Kundi, T Noesslinger, S Blum, P Geissler, ... Cancer 116 (10), 2372-2381, 2010 | 72 | 2010 |
| Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS A Kündgen, M Nomdedeu, H Tuechler, G Garcia-Manero, RS Komrokji, ... Leukemia 35 (3), 835-849, 2021 | 68 | 2021 |
| Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7. S Knipp, B Hildebrandt, J Richter, R Haas, U Germing, N Gattermann Haematologica 90 (5), 691-693, 2005 | 63 | 2005 |
| A WHO Classification-Based Prognostic Scoring System (WPSS) for Predicting Survival in Myelodysplastic Syndromes. L Malcovati, U Germing, A Kuendgen, MG Della Porta, R Invernizzi, ... Blood 106 (11), 788, 2005 | 50 | 2005 |
| Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement S Knipp, N Gattermann, M Schapira, H Käferstein, U Germing Leukemia research 31 (11), 1585-1587, 2007 | 43 | 2007 |
| Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome S Knipp, C Strupp, N Gattermann, B Hildebrandt, M Schapira, ... Leukemia research 32 (1), 33-37, 2008 | 41 | 2008 |
| Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes J Schemenau, S Baldus, M Anlauf, P Reinecke, S Braunstein, S Blum, ... European journal of haematology 95 (3), 181-189, 2015 | 40 | 2015 |
| Relapsing polychondritis in childhood–case report and short review S Knipp, H Bier, G Horneff, C Specker, A Schuster, H Schroten, ... Rheumatology international 19, 231-234, 2000 | 37 | 2000 |
